Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Impact of the Low FODMAP Diet on Gastrointestinal Symptoms and Nutritional Status in People With Small Intestinal Bacterial Overgrowth (SIBO)

NCT07424313 is registered in ClinicalTrials.gov with Warsaw University of Life Sciences as lead sponsor.

NCT NCT07424313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07424313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Impact of the Low FODMAP Diet on Gastrointestinal Symptoms and Nutritional Status in People With Small Intestinal Bacterial Overgrowth (SIBO)
Lead sponsor
Warsaw University of Life Sciences
Phase
Not applicable
Overall status
Completed
Start date
February 8, 2024
Completion date
January 15, 2026
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sibo, small intestinal bacterial overgrowth, small intestinal bacterial overgrowth syndrome (sibo)